Ophthalmic composition
Disclosed is an ophthalmic composition which is characterized by containing (A) a vitamin A, (B) a polyoxyethylene polyoxypropylene glycol, and (C) an oil component that is selected from the group consisting of castor oil, soybean oil, sesame oil, peanut oil, olive oil, almond oil, wheat germ oil, corn oil, rapeseed oil, sunflower oil, purified lanolin and gel hydrocarbon.
1. An ophthalmic composition comprising:
(A) 50,000 to 500,000 units/100 mL of vitamin A,
(B) 0.2 to 10 W/V % of a polyoxyethylene polyoxypropylene glycol selected from the group consisting of polyoxyethylene ( 200 ) polyoxypropylene ( 70 ) glycol, polyoxyethylene ( 160 ) polyoxypropylene ( 30 ) glycol, and polyoxyethylene ( 54 ) polyoxypropylene ( 39 ) glycol,
(C) 0.01 to 5 W/V % of an oil ingredient selected from the group consisting of castor oil, soybean oil, sesame oil, olive oil, almond oil, wheat germ oil, corn oil, canola oil, sunflower oil, and purified lanolin,
(D) 0.001 to 0.5 W/V % of vitamin E or dibutylhydroxytoluene,
(E) 0.001 to 1.0 W/V % of a polyoxyethylene hardened castor oil and/or a polyoxyethylene sorbitain fatty acid ester,
sodium edetate,
boric acid, and
trometamol; and
wherein a total content of the ingredients (B) and (E) is 1.1 to 20.001 W/V %; and
wherein said composition contains no antiseptic selected from the group consisting of benzalkonium chloride, benzethonium chloride, sorbic acid or a salt thereof, paraoxybenzoic acid esters, chlorhexidine gluconate, thimerosal, phenyl ethyl alcohol, alkyldiaminoethylglycine hydrochloride, polyhexanide hydrochloride, and polydronium chloride.
2. The ophthalmic composition of claim 1 , wherein the ingredient (A) is retinol palmitate, retinol acetate or retinoic acid.
3. The ophthalmic composition of claim 1 , wherein said composition is the ophthalmic composition for contact lens.
4. The ophthalmic composition of claim 1 , wherein ingredient (C) is castor oil.
5. A method for treating dry eye, which comprises the administration an ophthalmic composition according to claim 1 .
6. The method of claim 5 , wherein the ophthalmic composition is formulated with no antiseptic.
7. The method of claim 5 , wherein the ingredient (A) is retinol palmitate, retinol acetate or retinoic acid.
8. The method of claim 5 , wherein said composition is the ophthalmic composition for contact lens.
9. The method of claim 5 , wherein ingredient (C) is castor oil.
10. An ophthalmic composition consisting of:
(A) 50,000 to 500,000 units/100 mL of vitamin A,
(B) 0.2 to 10 W/V % of polyoxyethylene polyoxypropylene glycol selected from the group consisting of polyoxyethylene ( 200 ) polyoxypropylene ( 70 ) glycol, polyoxyethylene ( 160 ) polyoxypropylene ( 30 ) glycol, and polyoxyethylene ( 54 ) polyoxypropylene ( 39 ) glycol,
(C) 0.01 to 5 W/V % of an oil ingredient selected from the group consisting of castor oil, soybean oil, sesame oil, peanut oil, olive oil, almond oil, wheat germ oil, corn oil, canola oil, sunflower oil and purified lanolin,
(D) 0.001 to 0.5 W/V % of vitamin E or dibutylhydroxytoluene,
(E) 0.001 to 1.0 W/V % of a polyoxyethylene hardened castor oil and/or a polyoxyethylene sorbitan fatty acid ester,
sodium edetate,
boric acid,
trometamol, and
optionally at least one selected from the group consisting of polyhydric alcohols, surfactants other than the ingredients (B) and (E), buffering agents, thickening agents, sugars, pH adjusters, tonicity agents, stabilizing agents, cooling agents, drugs, and water; and
wherein a total content of the ingredients (B) and (E) is 1.1 to 20.001 W/V %, and
wherein said composition contains no antiseptic selected from the group consisting of benzalkonium chloride, benzethonium chloride, sorbic acid or a salt thereof, paraoxybenzoic acid esters, chlorhexidine gluconate, thimerosal, phenyl ethyl alcohol, alkyldiaminoethylglycine hydrochloride, polyhexanide hydrochloride, and polydronium chloride.